ライフサイエンスコーパス: body dysmorphic disorder

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 s from the first relapse prevention study in body dysmorphic disorder.

2 score >/=9 was used as a positive screen for body dysmorphic disorder.

3 rs examined the prevalence and correlates of body dysmorphic disorder, a debilitating and chronic con

4 case notes of 100 consecutive patients with body dysmorphic disorder and compared with the same info

5 fective than desipramine in the treatment of body dysmorphic disorder and is effective even among tho

6 -compulsive disorder (OCD), 20 patients with body dysmorphic disorder, and 10 patients with mood diso

7 hors hypothesized that because patients with body dysmorphic disorder are preoccupied with their appe

8 rs estimated the overall point prevalence of body dysmorphic disorder as 0.7% in women in this age ra

9 ve data have indicated that individuals with body dysmorphic disorder (BDD) have high rates of suicid

10 Body dysmorphic disorder (BDD) is a psychiatric disorder

11 Body dysmorphic disorder (BDD) is a severe psychiatric c

12 Body dysmorphic disorder (BDD) is characterized by preoc

13 Research on the pharmacotherapy of body dysmorphic disorder (BDD), a common and often disab

14 This study investigated the course of body dysmorphic disorder (BDD), a relatively common and

15 rown Obsessive Compulsive Scale Modified for Body Dysmorphic Disorder (BDD-YBOCS) (the primary outcom

16 Twenty percent of the patients with body dysmorphic disorder had an occupation or education

17 The prevalence of body dysmorphic disorder in an oculofacial surgical sett

18 Muscle dysmorphia is a form of body dysmorphic disorder in which individuals develop a

19 Body dysmorphic disorder is common, distressing, and oft

20 Their estimate of the point prevalence of body dysmorphic disorder is consistent with data from a

21 Onset of body dysmorphic disorder is usually gradual during adole

22 Body dysmorphic disorder (preoccupation with an imagined

23 Adults (N=100) with DSM-IV body dysmorphic disorder received open-label escitalopra

24 Body dysmorphic disorder severity (in both the intent-to

25 ere were no significant group differences in body dysmorphic disorder severity or insight, depressive

26 Among escitalopram-treated subjects, body dysmorphic disorder severity significantly decrease

27 Body dysmorphic disorder severity significantly improved

28 utcome measures included specific ratings of body dysmorphic disorder severity, delusionality, and fu

29 ior to desipramine in the acute treatment of body dysmorphic disorder symptoms as measured by assessm

30 plausible explanation is that patients with body dysmorphic disorder tend to have an interest in aes

31 Patients screening positively for body dysmorphic disorder tend to have higher postoperati

32 nin reuptake inhibitors may be effective for body dysmorphic disorder, to date no controlled treatmen

33 The authors found that the presence of body dysmorphic disorder was linked to the presence of m

34 The presence of body dysmorphic disorder was significantly associated wi

35 Rates and diagnostic correlates of body dysmorphic disorder were examined by using data fro

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。